Haemonetics announces Q2 FY2026 results; no figures in provided text

HAEMONETICS CORP

2026-Q2 EPS reported $1.51 revenue$648,709,000

The company issued a press release on November 6, 2025 for its second quarter ended September 27, 2025.
First half fiscal 2026 results are also included in the release.
Specific financial results (revenue, EPS, etc.) are not available in the excerpt provided here.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.